Lupus (SLE) Treatment
系统性红斑狼疮治疗
Duration
6-12 months initial stabilization
Recovery
3-6 months to achieve disease control
Savings
~75% vs US
Average savings compared to US prices
Multidisciplinary systemic lupus erythematosus management utilizing immunosuppressants, biologics, and organ-specific interventions. China has extensive clinical experience treating lupus given its higher prevalence in Asian populations. Leading centers like Peking Union Medical College Hospital offer cutting-edge treatments including belimumab and novel targeted therapies.
Disease Activity Assessment
Complete lupus workup including ANA panel, complement levels, organ function tests, and SLEDAI scoring
Duration: 2-3 daysImmunosuppressive Protocol
Tailored immunosuppression with hydroxychloroquine, mycophenolate, or cyclophosphamide based on organ involvement
Duration: 1-3 monthsBiologic Addition
Consider belimumab or anifrolumab for refractory cases or to reduce steroid dependence
Duration: 3-6 monthsLong-term Monitoring
Regular flare monitoring, organ protection strategies, and medication tapering protocols
Duration: Ongoing- High clinical expertise due to large lupus patient population in China
- Access to novel Chinese-developed lupus biologics
- Integrated nephrology and dermatology support
- Significantly lower medication and monitoring costs
- Serious infection risk from immunosuppression
- Potential organ damage if undertreated
- Medication side effects including bone loss and metabolic changes
- Disease flares during treatment adjustments
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.